Update on NAYZILAM® Availability

drug news

Epilepsy News From:

Monday, October 5, 2020

We have been made aware that there is a temporary shortage of NAYZILAM® (midazolam) nasal spray, which is a newly approved rescue medication for break-through seizures. This shortage is due to an unforeseen manufacturing delay that is not COVID-related. The delay is not a result of a safety or medical issue.

In early October, supply in the local pharmacies will be limited, but the expectation is that Nayzliam will be available again in late October.

The company manufacturing Nayzilam has set up an information and assistance phone number and email for individuals who may be affected by this shortage.

There are medications other than Nayzilam which can be used as Rescue Therapy. Please talk to your health care provider for alternative rescue options if you are affected by this shortage.

 

Authored by: Elaine Wirrell MD on 10/2020

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

 
24/7 helpline